GAST and digestive system carcinoma: Accumulating evidence showed that gastrin signaling via CCK2R stimulates the growth of gastrointestinal cancer cells in vitro and in vivo, indicating blockade of CCK2R pathway might present a promising strategy for the treatment of gastrointestinal carcinoma.